Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xylometazoline 0.1% / Dexpanthenol 5% nasal spray
1202020R0AAAAAA
|
Xylometazoline hydrochloride/dexpanthenol | Xylometazoline hydrochloride/dexpanthenol | Ear, Nose and Oropharynx | 8 |
|
Dichlorobenzyl alcohol 1.2mg/Amylmetacresol 600microg loz SF
1203030AAAAAAAA
|
Dichlorobenzyl alcohol/amylmetacresol | Dichlorobenzyl alcohol/amylmetacresol | Ear, Nose and Oropharynx | 7 |
|
Diclofenac 0.074% mouthwash sugar free
1203040AAAAAAAA
|
Diclofenac sodium (Mouthwash) | Diclofenac sod | Ear, Nose and Oropharynx | 7 |
|
Pollenase Hayfever 50micrograms/dose nasal spray
1202010C0BKABAA
|
Pollenase (Nasal) | Beclometasone dipropionate | Ear, Nose and Oropharynx | 7 |
|
Sudafed Plus Blocked Nose 1mg/ml / 50mg/ml nasal spray
1202020R0BBAAAA
|
Sudafed Plus (Nasal) | Xylometazoline hydrochloride/dexpanthenol | Ear, Nose and Oropharynx | 7 |
|
Generic Sofradex ear/eye drops
120101040AAAAAA
|
Dexamethasone sodium metasulphbenzoate | Dexamethasone sodium metasulphobenzoate | Ear, Nose and Oropharynx | 6 |
|
Lidocaine 0.66% / Aminoacridine 0.05% oromucosal gel
1203010Q0AAAAAA
|
Lidocaine hydrochloride (Mouthwash) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 6 |
|
Sodium chloride compound mouthwash
1203040P0AAAAAA
|
Sodium chloride (Mouthwash) | Sodium chloride | Ear, Nose and Oropharynx | 6 |
|
Ultra Chloraseptic 0.71% anaesthetic throat spray cherry
1203030B0BQABAI
|
Ultra Chloraseptic | Benzocaine | Ear, Nose and Oropharynx | 6 |
|
Benzocaine 5mg / Tyrothricin 1mg lozenges
1203030B0AAACAC
|
Benzocaine (Antiseptic lozenge/spray) | Benzocaine | Ear, Nose and Oropharynx | 5 |
|
Ultra Chloraseptic 0.71% anaesthetic throat spy blackcurrant
1203030B0BQACAI
|
Ultra Chloraseptic | Benzocaine | Ear, Nose and Oropharynx | 5 |
|
Bonjela Teething gel
1203010Q0BLAAAP
|
Bonjela (Teething) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 4 |
|
Generic Anbesol Adult Strength gel sugar free
1203010Q0AAAIAI
|
Lidocaine hydrochloride (Mouthwash) | Lidocaine hydrochloride | Ear, Nose and Oropharynx | 4 |
|
Hydrogen peroxide 1.5% ear drops
1201010S0AAAAAA
|
Hydrogen peroxide (Ear) | Hydrogen peroxide | Ear, Nose and Oropharynx | 4 |
|
Salicylic acid 1% / Rhubarb extract 5% oromucosal solution
1203010S0AAAAAA
|
Generic solution | Salicylic acid | Ear, Nose and Oropharynx | 4 |
|
Betamethasone 0.05%/Doxycycline 10%/Nystatin 2% m/wash sach
1203010W0AAAAAA
|
Betamethasone/Doxycyline/Nystatin | Betamethasone/Doxycycline/Nystatin | Ear, Nose and Oropharynx | 3 |
|
Dequadin 250microgram lozenges
1203030F0BBAAAA
|
Dequadin | Dequalinium chloride | Ear, Nose and Oropharynx | 3 |
|
Generic Earex ear drops
1201030H0AAAEAE
|
Oils for the ear | Oils for the ear | Ear, Nose and Oropharynx | 3 |
|
Generic Otosporin ear drops
1201010Q0AAACAC
|
Hydrocortisone (Ear) | Hydrocortisone | Ear, Nose and Oropharynx | 3 |
|
Happinose 0.3% ointment
120202000BJBFAN
|
Proprietary compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | 3 |
|
Sodium chloride 7% nebuliser liquid 5ml ampoules
1202020L0AABNBN
|
Sodium chloride (Nasal) | Sodium chloride | Ear, Nose and Oropharynx | 3 |
|
Sudafed Sinus-Ease 0.1% nasal spray
1202020P0BJAEAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 3 |
|
Tyrozets lozenges
1203030B0BGAAAC
|
Tyrozets | Benzocaine | Ear, Nose and Oropharynx | 3 |
|
Aluminium acetate 13% ear drops
1201010C0AAABAB
|
Aluminium acetate (Ear) | Aluminium acetate | Ear, Nose and Oropharynx | 2 |
|
Buttercup Bronchostop Cough pastilles
120303000BBBYAI
|
Proprietary compound preparation BNF 1203030 | Other lozenge and spray preparations | Ear, Nose and Oropharynx | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.